scholarly journals Metastatic appendiceal cancer treated with Yttrium 90 radioembolization and systemic chemotherapy: A case report

2019 ◽  
Vol 11 (13) ◽  
pp. 116-125 ◽  
Author(s):  
Ambarish P Bhat ◽  
Philip A Schuchardt ◽  
Roopa Bhat ◽  
Ryan M Davis ◽  
Sindhu Singh
Keyword(s):  
Case Report ◽  
Systemic Chemotherapy ◽  
Appendiceal Cancer ◽  
Yttrium 90

Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: A case report

1990 ◽  
Vol 18 (1) ◽  
pp. 68-71
Author(s):  
Clarence B. Vaughn ◽  
Janet L. Chapman ◽  
Barry R. Herschman ◽  
Michael J. Bonczak ◽  
Edward J. Treisman ◽  
...  
Keyword(s):  
Case Report ◽  
Systemic Chemotherapy ◽  
Endometrial Adenocarcinoma

scholarly journals Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report

2021 ◽  
Vol 2021 (4) ◽  
Author(s):  
Jacqueline B Baikovitz ◽  
Lindsay Thornton ◽  
Monica T Garcia-Buitrago ◽  
Alan S Livingstone ◽  
Matthew T Studenski ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Case Report ◽  
Liver Resection ◽  
Pathologic Response ◽  
Clinical Scenario ◽  
Complete Pathologic Response ◽  
Pathological Findings ◽  
Rigorous Approach ◽  
Yttrium 90

Abstract Yttrium-90 (Y-90) trans-arterial radioembolization (TARE) is used in the management of unresectable hepatocellular carcinoma (HCC). During the last 5 years, dosimetry software has been developed to allow for a more rigorous approach of dose prescription in Y-90 TARE. We present here a case study of a 77-year-old woman diagnosed with HCC, who underwent a Y-90 TARE as a bridge procedure to liver resection. This clinical scenario represents a unique opportunity to illustrate the predictive value of dosimetric findings correlating dosimetry with pathological findings. In this case, Y-90 TARE dosimetry was predictive of treatment response in which the tumor received a mean dose of 156 Gy and demonstrated a complete pathologic response.

scholarly journals Laparoscopic ileocecal resection can be applied for appendiceal cancer with an ileal fistula: A case report

2018 ◽  
Vol 52 ◽  
pp. 120-124 ◽  
Author(s):  
Junko Mukohyama ◽  
Yasuo Sumi ◽  
Kiyonori Kanemitsu ◽  
Hiroshi Hasegawa ◽  
Masashi Yamamoto ◽  
...  
Keyword(s):  
Case Report ◽  
Ileocecal Resection ◽  
Appendiceal Cancer ◽  
Laparoscopic Ileocecal Resection

Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review

2012 ◽  
Vol 2 (1) ◽  
pp. 36-40 ◽  
Author(s):  
Kenji Tsuchihashi ◽  
Kotoe Takayoshi ◽  
Keita Uchino ◽  
Tsuyoshi Shirakawa ◽  
Hozumi Kumagai ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Systemic Chemotherapy ◽  
Appendiceal Adenocarcinoma

Cure of metastatic uterine carcinosarcoma to lungs: A case report

2003 ◽  
Vol 13 (1) ◽  
pp. 88-89
Author(s):  
A. Shamseddine ◽  
A. Taher ◽  
Y. Abou-Mourad ◽  
M. Seoud ◽  
A. Khalil
Keyword(s):  
Case Report ◽  
Systemic Chemotherapy ◽  
Pulmonary Nodules ◽  
Total Abdominal Hysterectomy ◽  
Abdominal Hysterectomy ◽  
Uterine Sarcoma ◽  
Uterine Carcinosarcoma ◽  
Pelvic Radiotherapy ◽  
Term Survival

Most patients with advanced or recurrent uterine sarcoma experience disease progression and ultimately die. We present a case of uterine sarcoma with lung metastasis treated with systemic chemotherapy and with no evidence of disease for more than 5 years. A 77-year-old woman underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy for carcinosarcoma of the uterus followed by external pelvic radiotherapy. Ten months later, the tumor recurred in the apex of the vagina and was treated with brachytherapy. After 6 months of remission, she presented with pulmonary metastasis. After four cycles of systemic chemotherapy with cisplatin and ifosfamide, the pulmonary nodules completely disappeared. Currently she is still in complete remission after more than 5 years, but unfortunately she has developed myelodysplastic syndrome. This is the first reported case in the literature of cured metastatic uterine carcinosarcoma to lungs, with long-term survival of 5 years.

scholarly journals Primary Small Cell Carcinoma of the Hypopharynx: A Case Report of a Rare Tumor

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Ali Bayram ◽  
Ebru Akay ◽  
Sema S. Göksu ◽  
İbrahim Özcan
Keyword(s):  
Case Report ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Systemic Chemotherapy ◽  
Metastatic Potential ◽  
Pyriform Sinus ◽  
Small Cell ◽  
Rare Tumor ◽  
History Of ◽  
The Right

Introduction. Primary hypopharynx involvement of small cell carcinoma is very rare and very few cases have been reported in the literature. Here, we report a case of primary small cell carcinoma of the hypopharynx in a male patient.Case Report. A 50-year-old man presented with a 6-month history of sore throat and swellings in the right side of the neck. Direct laryngoscopy and biopsy revealed small cell carcinoma of the hypopharynx located in the right pyriform sinus.Discussion. Small cell carcinoma of the hypopharynx has no clear treatment modality due to the rarity of the disease. Systemic chemotherapy and radiotherapy should have priority among the therapy regimens because of the high metastatic potential of the tumor.

Sign in / Sign up

Export Citation Format

Share Document